Neuroprotective effect of weak static magnetic fields in primary neuronal cultures

M Ben Yakir-Blumkin1, Y Loboda1, L Schächter2

  • 1Department of Molecular Pharmacology, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, 31096 Haifa, Israel.

Neuroscience
|August 31, 2014
PubMed

Insights

Low intensity static magnetic fields (SMFs) protect neurons from apoptosis, a key process in neurodegenerative disorders. This study shows SMFs reduce neuronal cell death by modulating calcium ion influx, offering potential therapeutic strategies.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biophysics

Background:

  • Static magnetic fields (SMFs) influence biological processes, including apoptosis.
  • Apoptosis is a critical mechanism in neurodegenerative diseases.
  • Previous research on SMF effects on apoptosis focused on non-neuronal cells.

Purpose of the Study:

  • To investigate the impact of low-intensity SMFs on neuronal survival in primary cortical and hippocampal neurons.
  • To model neurodegenerative states in vitro using primary neurons.
  • To elucidate the mechanisms underlying SMF-induced neuroprotection.

Main Methods:

  • Primary rat cortical and hippocampal neurons were exposed to SMFs (50G) for 7 days.
  • Etoposide (12μM) was used to induce apoptosis.
  • Apoptosis markers (cleaved PARP-1, cleaved caspase-3, active caspase-9, phospho-H2A), mitochondrial membrane potential, and calcium ion (Ca2+) influx via L-type voltage-gated channels (Cav1.2) were analyzed.

Main Results:

  • SMF exposure significantly reduced etoposide-induced apoptosis by 57.1% in cortical neurons.
  • SMFs decreased pro-apoptotic markers and mitochondrial membrane potential collapse.
  • The anti-apoptotic effect was mediated by Ca2+ influx through Cav1.2 channels, involving voltage- and store-operated Ca2+ channels.

Conclusions:

  • Low-intensity SMFs exert a protective effect against apoptosis in primary neurons.
  • The neuroprotective mechanism involves modulation of Ca2+ influx.
  • These findings suggest potential therapeutic applications of SMFs for neurodegenerative diseases.

Related Concept Videos